
Wall Street drifts as oil prices jump and US manufacturing slumps
NEW YORK (AP) — U.S. stocks are drifting on Monday following some discouraging updates on U.S. manufacturing, the area of the economy that President Donald Trump is trying to revive through his trade war and tariffs.
The S&P 500 was 0.3% lower in midday trading. The Dow Jones Industrial Average was down 236 points, or 0.6%, as of 11:30 a.m. Eastern time, and the Nasdaq composite was less than 0.1% lower.
Stocks dipped after a report from the Institute for Supply Management said U.S. manufacturing activity shrank by more last month than economists expected. Trump has been warning that U.S. businesses and households could feel some pain as he tries to use tariffs to bring more manufacturing jobs back to the country, but their on-and-off rollout has created lots of uncertainty.
'The impact of ever-changing trade policies of the current administration has wreaked havoc on suppliers' ability to react and remain profitable,' one company in the transportation equipment industry said in the ISM's survey.
Another in the computer and electronics products industry said, "Government spending cuts or delays, as well as tariffs, are raising hell with businesses. No one is willing to take on inventory risk.'
A separate report from S&P Global on manufacturing came in better than expected, but the overall figure 'masks worrying developments under the hood of the U.S. manufacturing economy,' said Chris Williamson, chief business economist at S&P Global Market Intelligence. He said uncertainty caused by tariffs has worries high about supplier delays and rising prices.
Monday's moves also came after more harsh rhetoric crossed between the world's two largest economies, just a few weeks after the United States and China had agreed to pause many of their tariffs that had threatened to drag the economy into a recession.
China blasted the United States on Monday for moves that it said hurt China's interests, including issuing AI chip export control guidelines, stopping the sale of chip design software to China and planning to revoke Chinese student visas.
'These practices seriously violate the consensus' reached during trade discussions in Geneva last month, the Commerce Ministry said in a statement. That followed President Donald Trump's accusation at the end of last week, where he said China was not living up to its end of the agreement that paused their tariffs against each other.
Hopes for lower tariffs because of trade deals that Trump could reach with other countries were the main reasons for a big rally on Wall Street last month, which brought the S&P 500 back within 3.8% of its all-time high. The index had dropped roughly 20% below the mark in April.
But Trump on Friday told Pennsylvania steelworkers he's doubling the tariff on steel imports to 50% to protect their industry, a dramatic increase that could further push up prices for a metal used to make housing, autos and other goods.
Later in a post on his Truth Social platform, Trump confirmed the steel tariff and said that aluminum tariffs would also be doubled to 50%. Both tariff hikes would go into effect Wednesday, Trump said.
That helped stocks of U.S. steelmakers climb. Nucor jumped 9.7%, and Steel Dynamics rallied 10%.
But automakers and other heavy users of metals weakened. General Motors reversed by 4.6%, and Ford fell 4.5%.
Lyra Therapeutics soared 419.5% after reporting positive late-stage trial results of an implant to treat chronic sinus inflammation in some patients.
Some of Monday's strongest action was in the oil market, where the price of crude climbed roughly 3%. The countries in the OPEC+ alliance decided to increase their production again, a move that often pushes crude prices down because it puts more on the market, but analysts said investors were widely expecting it. The past weekend's attacks by Ukraine in Russia also helped to raise uncertainty about the flow of oil and gas around the world.
A barrel of U.S. crude rose 3% to $62.61, while Brent crude, the international standard, gained 3.1% to $64.71.
In stock markets abroad, Hong Kong's Hang Seng fell 0.6% following the harsh words tossed between the United States and China. A report over the weekend also said that China's factory activity contracted in May, although the decline slowed from April.
Indexes also dipped across much of the rest of Asia and Europe. Japan's Nikkei 225 was one of the biggest movers after falling 1.3%.
In the bond market, Treasury yields rose as worries continue about how much debt the U.S. government will pile on due to plans to cut taxes and increase the deficit.
The yield on the 10-year Treasury rose to 4.45% from 4.41% late Friday and from just 4.01% roughly two months ago. That's a notable move for the bond market.
Besides making it more expensive for U.S. households and businesses to borrow money, such increases in Treasury yields can deter investors from paying high prices for stocks and other investments.
___
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

National Post
an hour ago
- National Post
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only
Article content GENT, Belgium & MALVERN, Pa. & TOKYO — H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G sTREM2 assay for the fully automated LUMIPULSE® G immunoassay analyzers. This CLEIA (chemiluminescent enzyme immunoassay) assay is available for Research Use Only (RUO) and allows for the quantitative measurement of soluble Triggering Receptor Expressed on Myeloid Cells 2 (sTREM2) in human cerebrospinal fluid (CSF) and blood within just 35 minutes. Article content sTREM2 is a promising biomarker of microglial activation, offering researchers insights into neuroinflammation linked to Alzheimer's and other neurodegenerative diseases. sTREM2 can be valuable for capturing the dynamics of inflammatory responses or for monitoring inflammatory modulators. This test complements Fujirebio's growing portfolio of neuro biomarkers, including GFAP, NfL, and pTau, and reinforces the company's leading position in advancing neuro biomarker research tools and diagnostics. Article content Article content 'By adding sTREM2 to our neuro portfolio, we're enabling a more comprehensive view of neurological disease mechanisms,' Article content said Goki Ishikawa, President and CEO of Fujirebio Holdings, Inc. 'sTREM2 complements established biomarkers like GFAP, NfL, and pTau by adding essential insight into neuroinflammation – offering a more complete picture of the disease on a single platform.' Article content The new test allows researchers and clinical research professionals to further study and understand the potential clinical utility of this promising microglial biomarker. The availability of the assay on the fully automated random access LUMIPULSE G analyzers gives researchers access to convenient, accurate, and robust measurement of sTREM2. Already widely available for routine use in neurological disease testing worldwide, these analyzers meet all necessary quality, throughput, and regulatory requirements. Article content About Fujirebio Article content Fujirebio, a member of H.U. Group Holdings Inc., is a global leader in the field of high-quality RUO and in vitro diagnostics (IVD) testing. It has more than 50 years' accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products. Article content Fujirebio was the first company to develop and market CSF biomarkers under the Innogenetics brand over 25 years ago. Fujirebio offers a comprehensive line-up of manual and fully automated assays for neurological diseases and consistently partners with organizations and clinical experts across the world to develop new pathways for earlier, easier and more complete neurodegenerative diagnostic tools. Article content Article content Article content Email: Article content pr@ Article content For investors and analysts: Article content Article content IR/SR Dept. Article content Article content Article content


Winnipeg Free Press
3 hours ago
- Winnipeg Free Press
Trump's 50 per cent steel and aluminum tariffs go into effect
WASHINGTON – Tariffs on imports of steel and aluminum to the United States are increasing to 50 per cent today after President Donald Trump followed through on his plan to double the duties. Trump signed an executive order Tuesday to increase the levies from their previous rate of 25 per cent, saying it was necessary to protect national security and industries in the United States. Prime Minister Mark Carney says the tariffs are both unlawful and unjustified and that Canada is intensively negotiating with the U.S. to have tariffs removed under a new economic and security deal. The latest steel and aluminum increase doesn't apply to imports from the United Kingdom, which remain at 25 per cent while the Trump administration works out details of a trade deal announced last month. About a quarter of all steel used in the United States is imported and Canada is its largest supplier. Monday Mornings The latest local business news and a lookahead to the coming week. The Canadian steel and aluminum industries say doubling the tariffs will have a devastating impact while economists warn the higher tariffs could also lead to cost increases for Americans. This report by The Canadian Press was first published June 4, 2025.

CTV News
3 hours ago
- CTV News
CTV National News: Steel and aluminum tariffs doubled as Trump's trade war escalates
CTV National News: Steel and aluminum tariffs doubled as Trump's trade war escalates Prime Minister Carney is calling U.S. President Trump's doubling of steel and aluminum tariffs 'unlawful and unjustified'. Rachel Aiello has the latest.